Schedule 13G ownership disclosure

MERSANA THERAPEUTICS INC

Common Stock, $0.0001 par value per share · CUSIP: 59045L205

Event date: 2026-01-06

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nextech Crossover I GP S.a. r.l.

    Shares: 0.00 · Class: 0.0%

  • Nextech Crossover I SCSp

    Shares: 0.00 · Class: 0.0%

  • Ian Charoub

    Shares: 0.00 · Class: 0.0%

  • Costas Constantinides

    Shares: 0.00 · Class: 0.0%

  • Rocco Sgobbo

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001916761-26-000002
Form type
SCHEDULE 13G/A
Filer
Mersana Therapeutics, Inc.
CIK
CIK 1442836
Filed
Jan 09, 2026
Reporting period
Jan 06, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub